HRT interaction with GLP-1 weight loss: what changes when you take both

Key takeaways

• Neither the Wegovy nor the Zepbound label names hormone therapy, but both medications slow stomach emptying, which may affect how oral medications are absorbed.
• Patches, gels, and sprays enter through the skin, so the stomach-emptying question centers on oral hormone therapy.
• Zepbound's label calls for backup or non-oral birth control after starting and after each dose increase, which matters in perimenopause.
• Small studies link hormone therapy with more weight loss on semaglutide and tirzepatide, but they don't show that hormone therapy caused it.
• Your menopause provider and your weight care clinician both need the full list of medications you take.

Will these two medications clash? That's the real question behind most searches about the HRT interaction with GLP-1 weight loss. If you take menopausal hormone therapy (HRT) and are considering a glucagon-like peptide-1 (GLP-1) medication such as Wegovy or Zepbound, here's a clear answer.

Headlines about HRT and GLP-1 medications focus on hormone therapy "boosting" weight loss. The practical question is safety and absorption: what happens to your estrogen patch or progesterone capsule when a medication slows your stomach?

This guide answers route by route: how each medication works, where they overlap, what the evidence shows, and what to ask your providers. Found-affiliated clinicians treat your HRT status as one of the biological inputs in a weight care plan.

Can you take HRT and a GLP-1 together?

Yes, women do take both, under medical supervision. Neither the Wegovy nor the Zepbound FDA label names menopausal hormone therapy as an interacting medication. In a 2026 Mayo Clinic study, 40 postmenopausal women used hormone therapy alongside tirzepatide for at least 12 months.

The main consideration is indirect. Both labels say the medication delays gastric emptying, meaning food leaves the stomach more slowly. Wegovy's label says this "may impact absorption" of oral medications taken at the same time, and Zepbound's label uses similar language.

No label or study reviewed for this article measures estrogen or progesterone levels in GLP-1 users. That question remains open.

The answer for you depends on your HRT route, whether you have a uterus, your GLP-1 dose stage, and your health history. GLP-1s are a safe option for many people after a full medical evaluation.

Hormone therapy carries its own risks. The 2026 Mayo Clinic study authors name blood clots in the veins (venous thromboembolism), stroke, and breast cancer. Weighing a GLP-1 in menopause means weighing both.

What HRT and GLP-1s each do

What HRT does (and doesn't do)

Hormone therapy replaces estrogen that declines in menopause. It's prescribed for menopausal symptoms, mainly hot flashes and night sweats, which clinicians call vasomotor symptoms. It isn't a weight-loss treatment.

Many regimens pair estrogen with progesterone for women who have a uterus. In the 2026 Mayo Clinic tirzepatide study, every hormone therapy user with a uterus also took 100 mg of oral progesterone daily.

Common routes include skin patches, gels, and sprays (transdermal routes), oral tablets, and vaginal estrogen. Some women use a progestin IUD, an intrauterine device that releases a synthetic form of progesterone.

What GLP-1 medications do

GLP-1 is a gut hormone that helps regulate appetite and blood sugar. GLP-1 agonists are medications that mimic it.

Semaglutide is the GLP-1 agonist in Wegovy, available as a weekly injection and, since December 2025, a daily pill. Tirzepatide (Zepbound) is a dual agonist, acting on GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors. This article uses "GLP-1s" as shorthand for all three.

Both FDA labels state that these medications delay gastric emptying. That slowdown is the link to HRT, since it may affect how swallowed medications are absorbed. Most questions about GLP-1 and estrogen, or tirzepatide and HRT, trace back to this one mechanism.

Why menopause changes the weight equation

Menopause shifts where your body stores fat. A 2021 analysis from the Study of Women's Health Across the Nation (SWAN) tracked 380 women for a median of 11.8 years. It used DXA scans, a low-dose X-ray that measures fat, lean tissue, and bone.

Visceral fat, the deep belly fat around your organs, held roughly steady before the menopause transition. It then rose about 6% a year during the transition in white women, the study's reference group. Japanese women showed no rise during the transition, and Black women showed no significant rise after menopause.

Earlier SWAN work, cited in that paper, describes fat gains alongside lean-mass losses across the transition. Waist size rose only gradually, so the scale can miss the shift.

According to 2021–2023 CDC data, 72.4% of US adults 20 and older have overweight or obesity. Among adults ages 40–59, 46.4% have obesity.

None of this reflects a lack of willpower. Found's core belief is that weight is shaped by biology, and menopause is biology at work. That's why GLP-1 for menopause weight gain is such a common question.

How GLP-1s can affect your HRT, route by route

The stomach-emptying question applies to what you swallow. Patches, gels, sprays, vaginal estrogen, and IUDs don't pass through the stomach. No study has measured hormone levels in women using HRT with a GLP-1, so this table is general education, not clinical guidance.

For Zepbound and an estrogen patch, the absorption question is mostly theoretical. Zepbound and progesterone capsules carry the standard oral caution.

Oral progesterone deserves extra attention. For women with a uterus, it's paired with estrogen, and unexpected bleeding is worth reporting. No label gives instructions here, so it's a point to raise with your prescriber.

Timing matters most at the start and after each dose increase. Zepbound's contraception guidance targets the four weeks after starting and after each dose step. Eli Lilly's prescriber site says the stomach-emptying delay "is largest after the first dose and diminishes over time."

For perspective, in pharmacology trials of the 1 mg semaglutide injection, semaglutide didn't affect absorption of oral medications. In a study of the tablet, the Wegovy label reports a 33% increase in exposure to levothyroxine, a thyroid hormone.

When tracking GLP-1 and HRT side effects, noting each dose-change date helps both prescribers spot patterns.

Wegovy, the Wegovy pill, and Zepbound: medication-specific notes

Zepbound is the only one of the three with a birth control instruction. Its label advises oral contraceptive users to switch to a non-oral method or add a barrier method, such as condoms. That applies for four weeks after starting and four weeks after each dose increase.

This matters for women in perimenopause who still use oral birth control. The guidance covers contraceptives only. Zepbound's label doesn't address menopausal hormone therapy or oral estradiol.

Novo Nordisk announced FDA approval of the Wegovy pill on December 22, 2025, and it has strict timing rules. The Wegovy label says to take it on an empty stomach in the morning with up to four ounces of water. Then wait at least 30 minutes before eating, drinking, or taking other oral medications.

That 30-minute window includes oral estradiol or progesterone taken the same morning. Fitting Wegovy and HRT into one routine may mean moving a dose, which is a prescriber conversation.

The Wegovy injection carries the general gastric-emptying caution, with no contraceptive instruction in its label. Ozempic contains the same active ingredient, semaglutide. Questions about Ozempic and estrogen follow similar lines, though this article draws only on Wegovy's labels.

Found prescribes all three, so a Found clinician can match the medication to your HRT routine. Every prescription is at the clinician's discretion.

Does HRT make GLP-1s work better? What the evidence says

Maybe, but the evidence is thin. Two small Mayo Clinic studies found women on hormone therapy lost more weight on GLP-1s, and neither can show hormone therapy caused the difference.

Retrospective means researchers reviewed existing records instead of randomly assigning treatment. That leaves room for a healthy-user effect, where women who use HRT differ in other ways that affect weight.

At last follow-up, the tirzepatide gap was 5.2 percentage points. The authors' "about 35% more weight lost" figure comes from the 15-month mark, when women on HT had lost 18.7% vs 13.7%. Its senior author said, "we cannot say hormone therapy caused additional weight loss." Headlines citing 17% vs 14% used preliminary conference figures.

In the trial pool, semaglutide produced meaningful weight loss at every menopausal stage. Only 10% of postmenopausal women in it used HT, and its authors said the HT question "requires further investigation."

These findings don't support starting hormone therapy for weight loss. Found's guide to HRT and GLP-1 for weight loss covers the fuller research story.

Perimenopause: a "start low, go slow" approach

Perimenopause is the stretch of irregular periods and shifting hormones before menopause. In the pooled STEP trials, women in perimenopause lost a median 17.7% on semaglutide injection, close to the 18.0% before menopause.

A lower-dose, gradual approach to GLP-1 and HRT in perimenopause may suit some women, though the right dose is individual. Contraception still matters, given Zepbound's four-week guidance for oral birth control.

There's no best HRT for weight loss in perimenopause, because hormone therapy treats menopausal symptoms rather than weight. Microdosing a GLP-1 in perimenopause is a separate tool.

Found's microdosing program offers early metabolic care for people with perimenopause, PCOS (polycystic ovary syndrome), or prediabetes. It starts low and goes slow, using daily oral tablets (Melts™) or a weekly injection with the same active ingredient as Ozempic®. A licensed clinician reviews your health history, and prescriptions are provided only if clinically appropriate.

Compounded GLP-1s aren't reviewed by the FDA for safety or efficacy and aren't approved to treat specific conditions. With any compounded medication, it's worth confirming clinician oversight, pharmacy licensing, and sourcing. Found is not affiliated with Novo Nordisk, maker of Ozempic®.

Protect muscle and bone while you lose

Part of the weight lost on GLP-1s is lean mass. In DXA substudies, lean mass made up about 25% of weight lost on tirzepatide and roughly 30% to 40% on semaglutide. A review in Acta Diabetologica, published online in November 2025, reports those figures.

Lean mass includes muscle, water, organs, and bone. The share is close to what diet-driven weight loss produces. Still, it adds to the lean-mass decline SWAN researchers describe across the menopause transition.

A 2025 joint advisory in the journal Obesity recommends strength training at least three times a week, and notes that higher protein targets, such as 1.2 to 1.6 grams per kilogram of body weight a day, have been proposed during active weight loss. Randomized trials testing protein specifically in GLP-1 users are still lacking.

Your Found coach can help fit strength training and protein into a routine you'll keep.

How to coordinate care between two prescribers

Two prescribers work best as one team when each sees the full picture. Found doesn't prescribe hormone therapy, so your menopause provider or ob-gyn keeps managing it. Found clinicians coordinate your weight care around your HRT.

Bring this checklist to both appointments:

• Share a full medication list, including your HRT route, dose, and timing.
• Flag your GLP-1 start date and each dose increase.
• Report unexpected bleeding, returning hot flashes, or persistent vomiting.
• Ask about backup contraception if you use oral birth control with Zepbound.
• Ask how to time oral HRT around the Wegovy pill's 30-minute wait.

Cost is part of coordination too. Found's free GLP-1 Coverage Checker contacts your insurer and returns a personalized report on coverage and estimated costs. Cash-pay options are available, with pricing set by each manufacturer's program, and coverage isn't guaranteed.

HRT interaction with GLP-1 weight loss FAQs

Does HRT make GLP-1 weight loss work better?

Two small retrospective Mayo Clinic studies link hormone therapy with more weight loss on semaglutide or tirzepatide. They show an association, and randomized trials are needed to test cause and effect.

Can I use an estrogen patch with Zepbound?

Zepbound's label doesn't name estrogen patches, and a patch enters through the skin rather than the stomach. No study has tested the pairing, so it's worth confirming with both prescribers.

Does Zepbound or Wegovy affect progesterone?

No label or study reviewed here measures progesterone levels on these medications. Both labels say slower stomach emptying may affect oral medications, so unexpected bleeding is worth reporting.

Should I start HRT or a GLP-1 first?

No study reviewed here compared starting orders, so the sequence is an individual decision with both prescribers. Hormone therapy decisions rest on menopausal symptoms and risks.

Do I need a lower GLP-1 dose if I'm on HRT?

Neither the Wegovy nor the Zepbound label calls for a dose change with hormone therapy. Your weight care clinician sets the dose based on your response and side effects.

Will weight loss injections make menopausal symptoms worse?

The studies reviewed here didn't measure menopausal symptoms on GLP-1s, so there's no evidence either way. Returning hot flashes are worth reporting to your menopause provider.

Can HRT cause weight gain?

Found's guide to menopause and weight gain covers this question in depth. Hormone therapy is prescribed for menopausal symptoms, and it isn't a weight management tool.

Build a weight care plan around your HRT

Taking HRT and a GLP-1 together comes down to coordination: the right route, the right timing, and two prescribers who share notes.

Found's approach, designed by doctors in obesity medicine, looks at your biology, including your HRT status, through MetabolicPrint™, Found's process designed by obesity medicine specialists to pinpoint your body's unique weight loss obstacles. Medication is one tool, alongside nutrition, movement, sleep, and coaching.

Found has served more than 300,000 members. To discover your MetabolicPrint and start your journey with Found, take our quiz. *Individual results may vary.

Curious how your HRT fits into a personalized weight care plan? Get started

This article is for general education and isn't medical advice. Talk with your health care providers before starting, stopping, or changing any medication.